- Home
- ETON vs NCMI Comparison
ETON vs NCMI Comparison
Compare ETON & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | NCMI |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 414.7M |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ETON | NCMI |
|---|---|---|
| Price | $18.95 | $3.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $31.00 | $5.90 |
| AVG Volume (30 Days) | 294.8K | ★ 555.6K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | N/A | ★ 52.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,011,000.00 | N/A |
| Revenue This Year | $107.23 | $11.13 |
| Revenue Next Year | $29.72 | $7.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $11.09 | $3.17 |
| 52 Week High | $23.00 | $6.18 |
Technical Indicators
Market Signals| Indicator | ETON | NCMI |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | 46.81 |
| Support Level | $16.04 | $3.17 |
| Resistance Level | $20.01 | $3.90 |
| Average True Range (ATR) | 1.07 | 0.18 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 70.28 | 32.46 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.